What if brilliant cutting-edge Alzheimer’s research ideas had the funding needed to get off the ground?
This is the question the drives the Alzheimer’s research grants of The Coins for Alzheimer’s Research Trust (CART) Fund.
It turns out that once CART provides funding for a great idea to prove its potential, other funding sources for the next round of research are often available.
A 2014 CART grant was used by Dr. Chuanhai Cao, of the University of South Florida Health Byrd Alzheimer’s Research Institute (USF) to investigate a potential Alzheimer’s vaccine. Cao’s research developed the CAO22W mutant peptide. Alzamend Neuro Inc. has licensed this peptide and is launching a Regulation A+ Tier II SEC Qualified Offering to continue the research.